ConcertAI Names Claudio D’Ambrosio, PhD, as Head of Biopharma Partnerships and RWE Solutions | News

BOSTON, Sept. 10, 2020 /PRNewswire/ — ConcertAI has hired Claudio D’Ambrosio, PhD, as head of biopharma partnerships and real-world evidence Solutions. Claudio brings over 15 years of experience as a cancer researcher, commercial leader, and strategic scientific partner to the life sciences industry to help advance the goals of ConcertAI of bringing rapid innovation and precision real-world evidence oncology to the world’s top global pharmaceutical companies.

ConcertAI is a fast-growing company with the leading technology for integrated Real-World Data (RWD), AI cloud solutions, and advanced outcomes, and data science services for oncology RWE). The mission of ConcertAI is to advance the regulatory and market access applications of precision RWE through a unique set of validated RWD solutions and complementary eurekaHealth technologies. 

“Claudio is a mission-driven leader with a deep knowledge of the disease biology, clinical practice, and research requirements of life science companies,” said Jeff Elton, PhD and

Read More